All Reports Events Blogs Videos
Showing 153 results
  • In the News
    May 14, 2026

    "Shared data allows the life sciences company to view the customer consistently across the organization, which means everyone is trying to drive the same outcomes for the customer instead of having a different view of the…
  • Blog
    May 13, 2026

    Since the launch of Claude Cowork, narratives suggesting that Artificial Intelligence (AI) will replace Software-as-a-Service (SaaS) platforms have gained significant momentum. We previously referred to this trend as the SaaSocalypse.  With the rise in vibe-coding and the rapidly advancing developer tools, many assume enterprises will increasingly build their own…
  • Blog
    April 28, 2026

    The marketplace is changing. Two marquee moves in July reset expectations for how large service providers will deliver operations at scale: Capgemini agreed to acquire WNS to build an agentic‑Artificial Intelligence (AI) powered intelligent operations leader,…
  • Blog
    April 09, 2026

    Veeva’s acquisition of Ostro reflects a shift in how life sciences engagement is evolving toward a model that is connected, conversational, and increasingly pull-based.  This shift matters because the industry’s commercial engagement model continues to face challenges. Life sciences…
  • Thematic Report
    March 26, 2026

    Pharmaceutical enterprises are reassessing their IT services sourcing strategies amid moderate growth, budget discipline, and rising innovation expectations. As provider consolidation intensifies, a small group of leading providers continues to capture a disproportionate share of enterprise…
  • Blog
    March 24, 2026

    Pharma Customer Relationship Management (CRM) is no longer a winner-takes-all market. For years, pharma CRM decisions were relatively straightforward, not because enterprises lacked strategic intent, but because the market offered limited real choice. That is now changing.  Since the onset of the COVID-19…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • LinkedIn Live
    Feb. 24, 2026

    Payer operations were reaching a structural inflection point. As cost pressure, regulatory scrutiny, and AI-enabled operating models reshaped the landscape, payer leaders had to rethink how sourcing and operating design delivered measurable business outcomes. In this…
  • PEAK Matrix®
    Feb. 19, 2026

    Healthcare payers are navigating volatile medical costs, limited premium growth, and fragmented legacy systems. At the same time, regulatory and quality requirements are intensifying, with the Centers for Medicare and Medicaid Services (CMS) advancing interoperability and…
  • Viewpoint
    Jan. 09, 2026

    As pharma enterprises modernize data architectures, automate workflows, and scale AI across the value chain, scientific expertise is becoming essential to realize meaningful outcomes from digital initiatives. Without scientific grounding, digital systems risk producing insights that…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • See Us At
    Dec. 09, 2025

    Join us for an exclusive evening AR/analyst networking party to kick off the holiday season. It’s a great opportunity to connect, celebrate, and recognize excellence across the analyst and AR community.  Register now This special event will also include the…
  • Press Release
    Dec. 03, 2025

    Everest Group has announced the release of a new Viewpoint report, The Future of CRM in Pharma: A Decision Framework to Navigate the Post Veeva–Salesforce Era, designed to guide pharmaceutical companies through pivotal CRM platform decisions following the conclusion…
  • Blog
    Nov. 18, 2025

    The next chapter of payer operations   The US healthcare landscape is grappling with rising costs, regulatory pressure, and eroding trust. Major payers such as UnitedHealth Group, Elevance, Humana, and CVS Health are reporting medical loss ratios (MLRs) near 88-90%, squeezing margins…
  • PEAK Matrix®
    Nov. 13, 2025

    Enterprises are elevating quality from a downstream test phase to a strategic engineering discipline woven through the software development life cycle. As digital, cloud, and AI programs scale, expectations shift from defect detection to resilience, velocity,…
  • Viewpoint
    Nov. 10, 2025

    As enterprises accelerate digital transformation and embrace next-generation technologies such as AI, generative AI, and cloud-native platforms, managing quality at scale has become increasingly complex. Traditional tool-centric quality approaches fall short in addressing fragmented processes, inconsistent…
  • State of the Market
    Oct. 31, 2025

    Clinical and Care Management (CCM) is becoming a strategic priority for healthcare enterprises, driven by the need to improve outcomes, contain costs, and comply with intensifying regulatory demands. Once seen primarily as a cost-control function, CCM…
  • PEAK Matrix®
    Oct. 29, 2025

    Enterprises are reimagining quality as a strategic engineering function rather than a downstream testing activity. As a result, demand for specialized Quality Engineering (QE) services is growing rapidly across industries. This analysis shows how the specialists…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…

Items per page